iShares Biotechnology ETF
667 hedge funds and large institutions have $5.08B invested in iShares Biotechnology ETF in 2020 Q1 according to their latest regulatory filings, with 80 funds opening new positions, 176 increasing their positions, 253 reducing their positions, and 116 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30% less repeat investments, than reductions
Existing positions increased: 176 | Existing positions reduced: 253
31% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 116
51% less call options, than puts
Call options by funds: $359M | Put options by funds: $729M
Holders
667
Holding in Top 10
14
Calls
$359M
Puts
$729M
Top Buyers
| 1 | +$133M | |
| 2 | +$36.3M | |
| 3 | +$35.3M | |
| 4 |
JG
Jefferies Group
New York
|
+$18M |
| 5 |
CB
Commerce Bank
Kansas City,
Missouri
|
+$15M |
Top Sellers
| 1 | -$330M | |
| 2 | -$135M | |
| 3 | -$112M | |
| 4 |
Two Sigma Investments
New York
|
-$77.2M |
| 5 |
Two Sigma Advisers
New York
|
-$51.5M |